Cherie Fathy, MD, MPH, is a Director of Clinical Research at Alnylam Pharmaceuticals. Prior to that, she was a Medical Officer for Cell and Gene Therapy Trials at FDA CBER. Dr. Fathy completed her ophthalmology residency at The Wills Eye Hospital and her fellowship at the Wilmer Eye Institute at Johns Hopkins.
